热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易

客户端

　　复宏汉霖（02696）早盘上涨9.23%，现报21.90港元，成交额2003.42万港元。

　　复宏汉霖公布，与Dr． Reddy‘s订立许可协议，据此，公司向Dr． Reddy’s授出一项许可，供其于美国及约定的欧洲地区内及领域内开发、生产和商业化HLX15（重组抗CD38全人单克隆抗体注射液）的静脉注射制剂与皮下注射制剂。根据协议条款，复宏汉霖将负责HLX15的研发、生产以及商业化供应，并从交易中获得1.316亿美元，其中3300万美元为交易首付款。

海量资讯、精准解读，尽在新浪财经APP

责任编辑：卢昱君

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.